drug

zelicapavir

1 story · latest Aug 10, 2026

Status: Investigational
Trials: 1 registered trial in coverage

Relationships

Developed by Enanta Pharmaceuticals Inc

Timeline

Enanta reports fiscal Q3 2026 results, dosing underway in pediatric RSV trial

Aug 10Quarterly updateEnanta Pharmaceuticals Inc zelicapavir

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.